Introduction
Spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME) is a rare autosomal recessive disease associated with mutations of ASAH1 gene, which encodes N-acylsphingosine amidohydrolase 1 [1] . It is characterized by progressive proximal muscle weakness due to anterior horn cell degeneration, followed by myoclonic seizures and cognitive decline [1] . Age of onset can range from childhood to adolescence [1, 2] . In addition to myoclonic seizures, absence, atonic, and rare generalized tonic-clonic seizures have been described [1, 2] . Abnormal eye movements and eyelid flutter have also been described but without an epileptiform EEG correlate [1, 2] .
Herein, we report an unusual clinical manifestation of SMA-PME syndrome, eyelid myoclonic status epilepticus (SE), which has not been previously reported and needed particular attention for the use of appropriate anti-epileptic drug treatments.
Case report
The patient was a girl aged 11 years from a Turkish family with first-degree consanguineous parents, born at the 38th gestational week by spontaneous delivery, with no problems during pregnancy. Her younger sibling died aged one year of an unknown etiology. Early motor and mental milestones were normal up to the age of 3 years. At the age of 4 years, the patient had trouble in climbing stairs, rising from the floor, and running; she was admitted to hospital and proximal lower extremity weakness predominantly in flexor muscle groups (Medical Research Council scale: 4/5) was found in her neurologic examination. Myoclonic jerks in her upper extremities developed at the age of 6 years. She was first treated with levetiracetam, which slightly reduced the frequency of myoclonia. However, over time, head drops, eyelid myoclonia, and rare generalized seizures developed and valproic acid was also used as an add-on treatment. Her seizures were poorly controlled with these antiepileptic drugs despite appropriate dosing and therapeutic blood levels. Her physical and neurologic conditiondeteriorated progressively, and she was wheelchair-bound at the age of 10 years. At the age of 11, she was no longer ambulatory and had prominent dysphagia. She was admitted to our emergency department with involuntary movements of the eyelids, which occurred for a few hours with 2-5 s interruptions. The eyelid movements appeared as jerking of the eyelids and were often accompanied by slight rolling of the eyeballs. Her video-EEG monitoring showed eyelid myoclonic SE, which did not respond to an initial dose of diazepam (Supplementary video). Seizures were controlled with intravenous valproic acid and midazolam after 1.5 h. After recurrent lung infections, the patient was admitted to the intensive care unit. She is now living with mechanical ventilation at home and feeding with percutaneous endoscopic gastrostomy.
Laboratory findings
Biochemical test results were normal including serum creatinine kinase (193 U/L). Lysosomal enzyme activities and metabolic screening were also unremarkable. Nerve conduction studies revealed normal sensory and motor nerve conductions. Needle electromyography (EMG) showed diffuse neurogenic changes with denervation potentials in the upper and lower extremities, which supported anterior horn disease. A muscle biopsy indicated atrophied type II fibers, hypertrophied type I fibers, and fiber grouping, which revealed typical denervation patterns.
EEG
The patient's first EEG at the age of 6 years revealed mild slowing of background activity with centro-parietal and occipital spike and waves (Fig. 1A-B) . At the age of 9 years, EEG showed spike and waves starting over the central regions with secondary generalization (Fig. 1C ). There were also generalized epileptiform discharges and sensitivity to intermittent photic stimulation and eye closure sensitivity (Fig. 1D) . At the age of 11 years, her video-EEG monitoring showed almost continuous 3-3.5-Hz irregular generalized spike and waves, and myoclonic SE of the eyelids, which could not be easily suppressed after diazepam infusion (Supplementary video).
Cranial magnetic resonance imaging performed at the age of 10 years showed mild cerebellar-vermian atrophy, and corticosubcortical atrophy with secondary ventricular dilatation ( Fig. 2A  and B ).
Molecular genetic investigations
Homozygous deletion of exon 7 and 8 of SMN1 gene was excluded. Sequencing of ASAH1 gene (NM_177924) revealed a homozygous c.125C>T (p.Thr42Met) mutation in exon two. Her parents and unique sibling were found to carry the same mutation in the heterozygous form (Fig. 2C) .
Discussion
We present the first patient with SMA-PME syndrome associated with myoclonic SE localized to the eyelids. In 2002, two different mutations in ASAH1 gene were first found in association with SMA-PME in three families, one of them originated from Turkey [1] . The authors observed the same c.125C>T mutation in two of the families, including the one from Turkey, and a gross deletion covering the entire ASAH1 gene [1] .
In the following period, two further missense mutations (p. Thr42Ala, p.Lys152Asn, which resulted in the disruption of donor splice site of intron six), three stop codons (p.Tyr59*, p.Gly284*, p. Arg296*), and one single nucleotide duplication that resulted in protein truncation (c.174dupC) were identified within the scope of SMA-PME [3] .
While abnormal eye movements and eyelid flutter have been described in association with these rare mutations, eyelid myoclonia and eyelid myoclonic SE with EEG correlate have not been previously described in the literature [2] . Thus, our patient is the first with SMA-PME to have eyelid myoclonic SE demonstrated using video EEG monitoring, which expands the seizure spectrum of this unique entity.
Notably, EEG recordings with background slowing and generalized spikes, polyspikes, and waves were described in previous reports [2] . The EEGs of our proband showed multifocal epileptic foci, especially in central and occipital regions, secondary bilateral hypersynchrony besides generalized spikes and polyspike waves, in addition to other published reports [2] . Eyelid myoclonia with or without absences are unique seizure types, but they have not yet been related with a specific genetic mutation [4] . These seizures have been reported in idiopathic/genetic generalized epilepsies including juvenile myoclonic epilepsy, juvenile absence epilepsy, in addition to the controversial syndrome of eyelid myoclonia with absences [4] . Hypothetically, our findings suggest that patients with eyelid myoclonia and eyelid myoclonic SE may harbor different genetic mutations in the ASAH1 gene.
In conclusion, we reported a patient with SMA-PME of a consanguineous Turkish family associated with ASAH1 gene mutation. This is the first case of SMA-PME with myoclonic SE of the eyelids. Thus, our findings have widened the classic clinical features of SMA-PME and supplied evidence for a wider spectrum of seizure phenotypes than previously appreciated. We propose that c.125C>T mutation in the ASAH1 gene may be responsible for the myoclonia of the eyelids, though this claim needs to be substantiated with more cases.
